WASHC1 and infection: We postulate that genetic or pharmacological approaches to promote WASH activation could lead to translational mechanisms to reduce neutrophil-mediated inflammation caused by exacerbated secretion of azurophilic granule proteases and pro-oxidant enzymes while maintaining some of the essential neutrophil responses to infection.